PITTSBURGH — The University of Pittsburgh School of Medicine is looking for adults to participate in a COVID-19 booster shot trial.
Pitt is one of 12 sites in the United States to be selected to take part in the National Institute of Allergy and Infectious Diseases clinical trial.
Adults who are fully vaccinated or will become fully vaccinated as part of the trial are being enrolled. They will receive a third “booster” dose of a COVID-19 vaccine.
In a news release Monday, Pitt said the trial will study the safety and immune response of a mixed-booster regimen.
“As more and more COVID-19 variants are identified, we need to figure out how we, as a community, can stay protected,” Judy Martin, M.D., professor of pediatrics at Pitt’s School of Medicine, said in a statement. “The study’s design is not to show whether we need booster shots. Its focus is identifying which vaccine combinations are safe and provide the most protection against the virus that causes COVID-19 and its variants.”
CLICK HERE for more information about the trial.
©2021 Cox Media Group